Page last updated: 2024-08-26

nicotine and mesalamine

nicotine has been researched along with mesalamine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's6 (50.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Bonner, GF1
Guslandi, M; Tittobello, A2
Guslandi, M1
Frego, R; Guslandi, M; Testoni, PA; Viale, E1
Courtney, E; Evans, BK; Green, JT; Hawkes, ND; Ingram, JR; Newcombe, RG; Pillai, S; Rhodes, J; Srivastava, ED; Swift, JL; Thomas, GA; Williams, GT1
Cohen, RD; Loftus, EV; Regueiro, M; Steinhart, AH1

Reviews

2 review(s) available for nicotine and mesalamine

ArticleYear
Current medical therapy for inflammatory bowel disease.
    Southern medical journal, 1996, Volume: 89, Issue:6

    Topics: Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Crohn Disease; Fatty Acids, Volatile; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Nicotine

1996
Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:10

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Clinical Trials as Topic; Colitis, Ulcerative; Drug Administration Routes; Drug Therapy, Combination; Escherichia coli; Fatty Acids, Volatile; Heparin; Humans; Immunologic Factors; Mesalamine; Nicotine; Probiotics; Proctitis; Remission Induction; Research Design; Treatment Outcome

2006

Trials

4 trial(s) available for nicotine and mesalamine

ArticleYear
Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis.
    Journal of gastroenterology, 1996, Volume: 31, Issue:4

    Topics: Administration, Cutaneous; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mesalamine; Nicotine; Pilot Projects; Recurrence; Steroids; Time Factors; Treatment Outcome

1996
Transdermal nicotine for ulcerative colitis.
    Annals of internal medicine, 1997, Sep-15, Volume: 127, Issue:6

    Topics: Administration, Cutaneous; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Mesalamine; Nicotine

1997
Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2002, Volume: 16, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Administration, Rectal; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Evaluation; Female; Humans; Male; Mesalamine; Middle Aged; Nicotine; Nicotinic Agonists; Severity of Illness Index; Single-Blind Method; Time Factors; Treatment Outcome

2002
A randomized trial of nicotine enemas for active ulcerative colitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Double-Blind Method; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Nicotine; Prednisolone; Sigmoidoscopy

2005

Other Studies

6 other study(ies) available for nicotine and mesalamine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study.
    International journal of colorectal disease, 1999, Volume: 14, Issue:4-5

    Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Mesalamine; Nicotine; Prednisone; Recurrence; Remission Induction

1999